5-10
2026
影响因子区间
—
平台估算
4%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:Emerging Infectious Diseases is an open-access, peer-reviewed journal published monthly by the Centers for Disease Control and Prevention (CDC). Note that beginning with Volume 26, the journal began publishing online-only. Publication in EID enables compliance with the NIH Public Access Policy.Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes. The conclusions, findings, and opinions expressed by authors contributing to Emerging Infectious Diseases do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.
【译文】新兴传染病是一种开放获取、同行评审的期刊,由疾病控制与预防中心(CDC)每月出版。请注意,从第26卷开始,该期刊开始仅在线出版。在EID上发表文章可符合NIH公共获取政策。新兴传染病遵循国际医学期刊编辑委员会关于在医学期刊中开展、报告、编辑和出版学术工作的建议。该期刊的同行评审过程允许由通常不是其编辑团队一部分的专家对提交的稿件进行批判性评估。作为一个独立出版物,该期刊的同行评审过程独立于CDC的审批流程。新兴传染病中作者所表达的观点、结论和发现并不一定反映美国卫生与公众服务部、公共卫生服务、疾病控制与预防中心或作者所属机构的官方立场。使用商标名称仅用于识别,并不表示公共卫生服务或美国卫生与公众服务部的认可。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 2区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |